Do Wall Street Analysts Like Globe Life Stock?

Core Insights - Globe Life Inc. has a market capitalization of $10.66 billion and offers a variety of life and supplemental health insurance solutions to millions of Americans, utilizing multiple distribution channels [1] Financial Performance - The company reported a 4% year-over-year increase in revenue for Q3 fiscal 2025, totaling $1.51 billion, slightly below Wall Street expectations [4] - Life premiums contributed to this growth, rising 3.2% year-over-year to $844.48 million [4] - Net operating income surged 37.8% year-over-year to $4.81 per share [4] Stock Performance - Globe Life's stock has risen 21.4% over the past 52 weeks and 11% over the past six months, outperforming the broader S&P 500 Index which gained 14.5% and 17.2% respectively during these periods [2] - Compared to its sector, the Financial Select Sector SPDR Fund (XLF) gained 7.9% over the past 52 weeks and 5.5% over the past six months, indicating Globe Life's stock has outperformed its sector as well [3] Future Projections - The company projects net operating income for fiscal 2025 to be between $14.40 and $14.60 per share, with expectations for fiscal 2026 ranging from $14.60 to $15.30 per share [5] - Analysts forecast a 17.9% year-over-year growth in EPS for fiscal 2025, reaching $14.58 on a diluted basis, and a 3.2% annual increase to $15.04 in fiscal 2026 [6]